(Q30240026)

12 June 2017

Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies (English)

1 reference

12 June 2017

1 reference

C Lanvers-Kaminsky

1

1 reference

12 June 2017

Ag Am Zehnhoff-Dinnesen

series ordinal

2

1 reference

12 June 2017

R Parfitt

series ordinal

3

1 reference

12 June 2017

G Ciarimboli

series ordinal

4

1 reference

12 June 2017

language of work or name

English

0 references

publication date

21 December 2016

1 reference

Clinical Pharmacology & Therapeutics

12 June 2017

1 reference

12 June 2017

101

1 reference

12 June 2017

4

1 reference

12 June 2017

491-500

1 reference

New developments in aminoglycoside therapy and ototoxicity

12 June 2017

1 reference

Understanding platinum-induced ototoxicity.

21 January 2018

1 reference

Auditory sensori-neural alterations induced by salicylate

21 January 2018

1 reference

Recovery from cisplatin-induced ototoxicity: a case report and review.

21 January 2018

1 reference

Molecular and clinical implications of loop diuretic ototoxicity

21 January 2018

1 reference

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention

21 January 2018

1 reference

The societal costs of severe to profound hearing loss in the United States

21 January 2018

1 reference

Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development

21 January 2018

1 reference

The importance of high-frequency audibility in the speech and language development of children with hearing loss.

21 January 2018

1 reference

21 January 2018

1 reference

Overview of psychologic effects of chronic dizziness and balance disorders

21 January 2018

1 reference

Potassium ion movement in the inner ear: insights from genetic disease and mouse models

21 January 2018

1 reference

Cochlear outer hair cell motility

21 January 2018

1 reference

21 January 2018

The vestibular system

1 reference

Platinum-based drugs: past, present and future

21 January 2018

1 reference

Cellular processing of platinum anticancer drugs

21 January 2018

1 reference

Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity

21 January 2018

1 reference

Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs

21 January 2018

1 reference

Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions

21 January 2018

1 reference

Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.

21 January 2018

1 reference

Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale

21 January 2018

1 reference

Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy.

21 January 2018

1 reference

Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration.

21 January 2018

1 reference

Blood-perilymph barrier and ototoxicity: an in vivo study in the rat.

21 January 2018

1 reference

Mechanisms of cisplatin-induced ototoxicity and prevention

21 January 2018

1 reference

Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis.

21 January 2018

1 reference

Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides

21 January 2018

1 reference

Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity

21 January 2018

1 reference

Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs

21 January 2018

1 reference

Integrity and regeneration of mechanotransduction machinery regulate aminoglycoside entry and sensory cell death

21 January 2018

1 reference

Entry of aminoglycosides into renal tubular epithelial cells via endocytosis-dependent and endocytosis-independent pathways

21 January 2018

1 reference

Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness

21 January 2018

1 reference

Stimulation of free radical formation by aminoglycoside antibiotics

21 January 2018

1 reference

Ternary complexes of gentamicin with iron and lipid catalyze formation of reactive oxygen species

21 January 2018

1 reference

Evidence That Antibiotics Bind to Human Mitochondrial Ribosomal RNA Has Implications for Aminoglycoside Toxicity.

21 January 2018

1 reference

Prevalence of mitochondrial gene mutations among hearing impaired patients

21 January 2018

1 reference

Prevalence of mitochondrial 1555A-->G mutation in adults of European descent.

21 January 2018

1 reference

Salicylate-induced cochlear impairments, cortical hyperactivity and re-tuning, and tinnitus

21 January 2018

1 reference

Functional hair cell mechanotransducer channels are required for aminoglycoside ototoxicity

21 January 2018

1 reference

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria

21 January 2018

1 reference

Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter

21 January 2018

1 reference

Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease

21 January 2018

1 reference

Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report

21 January 2018

1 reference

Inhibitory effect of erythromycin on ion transport by stria vascularis and vestibular dark cells.

21 January 2018

1 reference

Vancomycin- and erythromycin-induced hearing loss in humans

21 January 2018

1 reference

Vancomycin ototoxicity: a reevaluation in an era of increasing doses

21 January 2018

1 reference

The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.

21 January 2018

1 reference

Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses.

21 January 2018

1 reference

Cisplatin ototoxicity in children: a practical grading system.

21 January 2018

1 reference

Practical grading system for evaluating cisplatin ototoxicity in children

21 January 2018

1 reference

[The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy].

21 January 2018

1 reference

Early cisplatin induced ototoxicity profile may predict the need for hearing support in children with medulloblastoma.

21 January 2018

1 reference

The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects

21 January 2018

1 reference

Future opportunities in preventing cisplatin induced ototoxicity

21 January 2018

1 reference

High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Preferential formation and decreased removal of cisplatin-DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CPT.603

1 reference

12 June 2017

1 reference